Sarcosine

Sarcosine

SCHEMBL8448408

CC(=O)C(N)C(=O)O.CNCC(=O)O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTH P32929 1/20 0.34
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
PTGS2 P35354 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GRIK1 P39086 2/20 0.31
GABRP O00591 2/20 0.31
GABRD O14764 2/20 0.31
GABRA1 P14867 2/20 0.31
GABRB1 P18505 2/20 0.31
GABRG2 P18507 2/20 0.31
GABRB3 P28472 2/20 0.31
GABRA5 P31644 2/20 0.31
GABRA3 P34903 2/20 0.31
GABRA2 P47869 2/20 0.31
GABRB2 P47870 2/20 0.31
GABRA4 P48169 2/20 0.31
GABRE P78334 2/20 0.31
GABRA6 Q16445 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sarcosine SCHEMBL17258535 0.81 ALDH1A1 (0.38) CTHALDH1A1LMNAMAPTPTGS2
Alanine SCHEMBL11511190 0.80 ALDH1A1 (0.40) ALDH1A1LMNAMAPTPTGS2TDP1
Alanine SCHEMBL28294968 0.80 ALDH1A1 (0.40) ALDH1A1LMNAMAPTPTGS2TDP1
Sarcosine SCHEMBL2368384 0.80 ALDH1A1 (0.40) ALDH1A1LMNAMAPTPTGS2TDP1
Sarcosine SCHEMBL27642283 0.80 ALDH1A1 (0.43) CTHALDH1A1LMNAMAPTPTGS2
Sarcosine SCHEMBL16758622 0.79 CTH (0.44) CTHALDH1A1LMNAMAPTPTGS2
SCHEMBL28803254 0.79 SLC7A5 (0.43) ALDH1A1LMNAMAPTGRIK1SLC7A5
SCHEMBL188495 0.79
SCHEMBL28803255 0.79 SLC7A5 (0.43) ALDH1A1LMNAMAPTGRIK1SLC7A5
SCHEMBL188494 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915841-A1 ANILINOPEPTIDE DERIVATIVES Novartis AG (CH) 1999-05-19 EP disclosed
WO-1998003476-A1 ANILINOPEPTIDE DERIVATIVES NOVARTIS AG (CH) 1998-01-29 WO disclosed